Researchers at the University of Texas Medical Branch at Galveston have successfully harnessed a Zika virus vaccine under development to target and kill the brain cancer known as glioblastoma. The findings are currently available in MBio.
The Zika virus can cause microcephaly, a condition where the fetal brain doesn't fully develop when a pregnant woman is infected with the virus. In contrast, glioblastoma dangerously multiplies brain cells into cancerous tumors. The altered Zika vaccine effectively targeted and destroyed the cancerous brain cells in mice but not healthy cells.
"These findings represent major progress toward developing the Zika vaccine as a safe and effective virotherapeutic treatment for human glioblastoma," said UTMB's Pei-Yong Shi, professor in the department of biochemistry and molecular biology.
Glioblastoma is the deadliest and most common type of brain tumor. Despite surgery, radiation and chemotherapy, glioblastoma has a high rate of return with an average survival of less than two years. The late Sen. John McCain's battle with glioblastoma has drawn into sharp focus how aggressive this form of brain cancer can be.
Glioblastoma is a cancer of the glial cells enmeshed throughout the brain that provide structure, nutrition and oxygen for the nerve cells. The tumor recurrence is likely due to cancerous glioblastoma stem cells that hide in brain tissue close to the tumor mass even after surgery. Microcephaly likely develops because Zika virus targets stem cells in the fetal brain.
These observations led Shi and his colleagues at UTMB and in China to test the safety and effectiveness of UTMB's potential Zika virus vaccine in treating mice that were given human glioblastoma tumors to see if the virus would infect and kill the glioblastoma stem cells without harming normal brain cells. They found that the Zika vaccine caused no neurological symptoms or behavioral abnormalities while significantly reducing tumor growth and prolonging survival.
"The current study takes advantage of our recently developed Zika vaccine candidate," Shi said. "We will continue to improve the therapeutic potential of this platform by increasing the safety and increasing the specific cancer-killing activity. It is exciting to turn the "bad" side of the virus into cancer treatment."
Other authors include UTMB's Chao Shan and Xuping Xie as well as Qi Chen, Jin Wu, Qing Ye, Chunfeng Li, Xiao-Feng Li, Xiaoling Qin, Tongyang Zhao and Cheng-Feng Qin from the Academy of Military Medical Sciences, Beijing, China; Feng Ma and Dapei Li from the Chinese Academy of Medical Sciences & Peking Union Medical College; Qian Zhu, Yan Wu and Haitao Wu from the Beijing Institute of Basic Medical Sciences, China; Xiaoyan Zhan and Jianghong Man from the National Center of Biomedical Analysis, Beijing, China.
Source: University of Texas Medical Branch at Galveston
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.
CenTrak Unveils Revolutionary BLE Multi-Mode Platform for Health Care RTLS Solutions
March 22nd 2024CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.